Insulin containing pharmaceutical compositions
US10596231B2 · kind B2 · utility
0Cited by
50References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 20, 2019 |
| Grant date | Mar 24, 2020 |
| Priority date | — |
| Expiry date | Feb 20, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/48
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is in the field of pharmaceutical compositions for the treatment of medical conditions relating to diabetes. More specifically the invention provides pharmaceutical compositions comprising a long-acting acylated derivative of a human insulin analogue, and to the medical use of such compositions for basal insulin administration therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.